C-MER Eye Care (03309) Repurchases 1.27 Million Shares for HK$4.9 Million Under Buyback Mandate

C-MER Medical (03309) announced that, as of the date of this announcement for the past five trading days, the company has repurchased 1.27 million shares from the market under the repurchase mandate, at a total cost of HKD 4.9 million (excluding brokerage commission, stamp duty, and other expenses). The highest repurchase price per share was HKD 3.94, and the lowest repurchase price per share was HKD 3.68. The company will subsequently cancel the repurchased shares.